drug · antibody
tibulizumab
Phase 2updated 6mo agoby $ZURA Zura Bio Ltd🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 2 3 (across all indications), with 2 investigational indications.
targets
Interleukin-17ATumor necrosis factor ligand superfamily member 13B
all catalysts(0)
nothing on the calendar yet
Trials studying tibulizumab
News(4)
- AstraZeneca buys vaccine startup; FDA issues GLP-1 safety warningThe deal gives AstraZeneca a simpler way to make conjugate vaccines. Elsewhere, a psychedelic depression drug was submitted to the FDA and an autoimmune disease-focused biotech’s shares collapsed.biopharma_dive · 5d ago
- STAT+: Gene therapy’s long-debated cancer risk materializesFor years, gene therapy researchers debated whether the viruses they use to ferry replacement genes into cells could cause tumors. A small number of cases now offer strong evidence that…stat · 7d ago
- Zura reports Phase 2 flop in painful skin disorder, stock nosedivesA small biotech’s stock collapsed after the company reported a Phase 2 failure in a debilitating skin condition. Zura Bio said Monday morning that both doses of its experimental drug tibulizumab fa…endpoints · 7d ago
- Zura scraps hidradenitis suppurativa program after phase 2 miss, sinking stockZura Bio’s tibulizumab has flunked a phase 2 hidradenitis suppurativa trial, prompting the biotech to end development in the indication while continuing studies in other settings.fiercebiotech · 8d ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that